Daniel Sepp

Daniel Sepp serves as Vice President/CTO at Vanguard Clinical, Inc.. Vanguard Clinical, Inc. operates in the research sector with approximately 53.0 employees.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Vanguard Clinical, Inc..
• • Our database includes 201,469 c suite-level executives.

Route 53 Sendgrid Outlook MailChimp SPF Facebook Login (Connect) Mobile Friendly Linkedin Widget Hubspot Facebook Widget Google Tag Manager Bootstrap Framework Google Analytics Gravity Forms WordPress.org Linkedin Login Remote

clinical operations clinical trial management clinical monitoring trial master file management clinical development vendor oversight cro oversight functional service provider biotechnology research contract research organization regulatory affairs data management pharmaceutical development patient recruitment biostatistics services medical writing quality assurance vendor management study start-up decentralized clinical trials therapeutic areas expertise study feasibility risk mitigation site management sop development regulatory submissions adverse event reporting study budget management clinical data management patient engagement sponsor relationships clinical trial execution white glove service clinical research expertise project management full-service cro flexible service offerings investigator brochures clinical study reports patient-centric solutions contract negotiation compliance monitoring training & education statistical methodology protocol compliance trial recovery innovative trial solutions global regulatory compliance trial efficiency therapeutics expertise productivity

TS

Tiffany Sepp President and CEO at Vanguard Clinical, Inc.

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Daniel Sepp in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Vanguard Clinical, Inc..

Daniel Sepp's Position in the MessageCEO Database

• •Daniel Sepp is 1 of 2 verified executive contacts we track at Vanguard Clinical, Inc..
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •14 verified contacts work at research companies in the 53.0 employee range (same size as Vanguard Clinical, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Daniel Sepp directly?

Daniel Sepp's verified email address is available to MessageCEO Pro subscribers. They currently serve as Vice President/CTO at Vanguard Clinical, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Daniel Sepp work for?

Daniel Sepp is Vice President/CTO at Vanguard Clinical, Inc., a company in the research sector with 53.0 employees.

Can I pitch or sell to Daniel Sepp?

As Vice President/CTO at Vanguard Clinical, Inc., Daniel Sepp is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Daniel Sepp directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Daniel Sepp in?

Daniel Sepp works in the research industry as Vice President/CTO at Vanguard Clinical, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Daniel Sepp's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Daniel Sepp's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026